Hepatitis E virus infection increases the risk of diabetes and severity of liver disease in patients with chronic hepatitis C virus infection

Detalhes bibliográficos
Autor(a) principal: Zitelli, Patricia Momoyo Yoshimura
Data de Publicação: 2021
Outros Autores: Gomes-Gouvêa, Michele, Mazo, Daniel F., Singer, Julio da Motta, Oliveira, Claudia P. M. S., Farias, Alberto Queiroz, Pinho, João Renato, Tanigawa, Ryan Yukimatsu, Alves, Venâncio Avancini Ferreira, Carrilho, Flair José, Pessoa, Mário Guimarães
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/212958
Resumo: OBJECTIVES: Co-infection with hepatitis A or B viruses may aggravate liver injury in patients infected with hepatitis C virus (HCV). However, few studies have assessed co-infection with hepatitis E virus (HEV) and HCV. Therefore, this study aimed to assess the prevalence and impact of HEV infection among Brazilian patients with chronic HCV infection. METHODS: This observational study included adult patients with chronic HCV infection who were naive to antiviral therapy from January 2013 to March 2016. A total of 181 patients were enrolled, and HEV serology and PCR were performed for all patients. RESULTS: Seropositivity for anti-HEV IgG was detected in 22 (12.0%) patients and anti-HEV immunoglobulin M in 3 (1.6%). HEV RNA showed inconclusive results in nine (4.9%) patients and was undetectable in the remaining patients. HEV serology positive patients had more severe liver disease, characterized by liver fibrosis ≥3 versus ≤2 (p<0.001), Aspartate Aminotransferase-to-Platelet Ratio Index of ≥1.45 (p=0.003), and Fibrosis-4 score of ≥3.25 (p=0.001). Additionally, the odds of HEV-positive patients developing diabetes mellitus were 3.65 (95% CI 1.40-9.52) times the corresponding odds of HEV-negative patients. A case-control-based histological analysis (n=11 HEV-HCV-positive patients and n=22 HCV-positive patients) showed no significant differences between the groups. CONCLUSIONS: This prevalence is higher than that reported in previous studies of the general population in Brazil. Thus, HEV infection may influence the severity of liver disease and may represent an additional risk of developing diabetes mellitus in patients with HCV infection.
id USP-19_ad0d02c62e9d3465f1ea189ad7817fe4
oai_identifier_str oai:revistas.usp.br:article/212958
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Hepatitis E virus infection increases the risk of diabetes and severity of liver disease in patients with chronic hepatitis C virus infectionHepatitis EHepatitis CChronicDiabetes MellitusLiver CirrhosisOBJECTIVES: Co-infection with hepatitis A or B viruses may aggravate liver injury in patients infected with hepatitis C virus (HCV). However, few studies have assessed co-infection with hepatitis E virus (HEV) and HCV. Therefore, this study aimed to assess the prevalence and impact of HEV infection among Brazilian patients with chronic HCV infection. METHODS: This observational study included adult patients with chronic HCV infection who were naive to antiviral therapy from January 2013 to March 2016. A total of 181 patients were enrolled, and HEV serology and PCR were performed for all patients. RESULTS: Seropositivity for anti-HEV IgG was detected in 22 (12.0%) patients and anti-HEV immunoglobulin M in 3 (1.6%). HEV RNA showed inconclusive results in nine (4.9%) patients and was undetectable in the remaining patients. HEV serology positive patients had more severe liver disease, characterized by liver fibrosis ≥3 versus ≤2 (p<0.001), Aspartate Aminotransferase-to-Platelet Ratio Index of ≥1.45 (p=0.003), and Fibrosis-4 score of ≥3.25 (p=0.001). Additionally, the odds of HEV-positive patients developing diabetes mellitus were 3.65 (95% CI 1.40-9.52) times the corresponding odds of HEV-negative patients. A case-control-based histological analysis (n=11 HEV-HCV-positive patients and n=22 HCV-positive patients) showed no significant differences between the groups. CONCLUSIONS: This prevalence is higher than that reported in previous studies of the general population in Brazil. Thus, HEV infection may influence the severity of liver disease and may represent an additional risk of developing diabetes mellitus in patients with HCV infection.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2021-11-26info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/21295810.6061/clinics/2021/e3270Clinics; Vol. 76 (2021); e3270Clinics; v. 76 (2021); e3270Clinics; Vol. 76 (2021); e32701980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/212958/194988Copyright (c) 2023 Clinicsinfo:eu-repo/semantics/openAccessZitelli, Patricia Momoyo YoshimuraGomes-Gouvêa, MicheleMazo, Daniel F.Singer, Julio da MottaOliveira, Claudia P. M. S.Farias, Alberto QueirozPinho, João RenatoTanigawa, Ryan YukimatsuAlves, Venâncio Avancini FerreiraCarrilho, Flair JoséPessoa, Mário Guimarães2023-07-06T13:04:05Zoai:revistas.usp.br:article/212958Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2023-07-06T13:04:05Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Hepatitis E virus infection increases the risk of diabetes and severity of liver disease in patients with chronic hepatitis C virus infection
title Hepatitis E virus infection increases the risk of diabetes and severity of liver disease in patients with chronic hepatitis C virus infection
spellingShingle Hepatitis E virus infection increases the risk of diabetes and severity of liver disease in patients with chronic hepatitis C virus infection
Zitelli, Patricia Momoyo Yoshimura
Hepatitis E
Hepatitis C
Chronic
Diabetes Mellitus
Liver Cirrhosis
title_short Hepatitis E virus infection increases the risk of diabetes and severity of liver disease in patients with chronic hepatitis C virus infection
title_full Hepatitis E virus infection increases the risk of diabetes and severity of liver disease in patients with chronic hepatitis C virus infection
title_fullStr Hepatitis E virus infection increases the risk of diabetes and severity of liver disease in patients with chronic hepatitis C virus infection
title_full_unstemmed Hepatitis E virus infection increases the risk of diabetes and severity of liver disease in patients with chronic hepatitis C virus infection
title_sort Hepatitis E virus infection increases the risk of diabetes and severity of liver disease in patients with chronic hepatitis C virus infection
author Zitelli, Patricia Momoyo Yoshimura
author_facet Zitelli, Patricia Momoyo Yoshimura
Gomes-Gouvêa, Michele
Mazo, Daniel F.
Singer, Julio da Motta
Oliveira, Claudia P. M. S.
Farias, Alberto Queiroz
Pinho, João Renato
Tanigawa, Ryan Yukimatsu
Alves, Venâncio Avancini Ferreira
Carrilho, Flair José
Pessoa, Mário Guimarães
author_role author
author2 Gomes-Gouvêa, Michele
Mazo, Daniel F.
Singer, Julio da Motta
Oliveira, Claudia P. M. S.
Farias, Alberto Queiroz
Pinho, João Renato
Tanigawa, Ryan Yukimatsu
Alves, Venâncio Avancini Ferreira
Carrilho, Flair José
Pessoa, Mário Guimarães
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Zitelli, Patricia Momoyo Yoshimura
Gomes-Gouvêa, Michele
Mazo, Daniel F.
Singer, Julio da Motta
Oliveira, Claudia P. M. S.
Farias, Alberto Queiroz
Pinho, João Renato
Tanigawa, Ryan Yukimatsu
Alves, Venâncio Avancini Ferreira
Carrilho, Flair José
Pessoa, Mário Guimarães
dc.subject.por.fl_str_mv Hepatitis E
Hepatitis C
Chronic
Diabetes Mellitus
Liver Cirrhosis
topic Hepatitis E
Hepatitis C
Chronic
Diabetes Mellitus
Liver Cirrhosis
description OBJECTIVES: Co-infection with hepatitis A or B viruses may aggravate liver injury in patients infected with hepatitis C virus (HCV). However, few studies have assessed co-infection with hepatitis E virus (HEV) and HCV. Therefore, this study aimed to assess the prevalence and impact of HEV infection among Brazilian patients with chronic HCV infection. METHODS: This observational study included adult patients with chronic HCV infection who were naive to antiviral therapy from January 2013 to March 2016. A total of 181 patients were enrolled, and HEV serology and PCR were performed for all patients. RESULTS: Seropositivity for anti-HEV IgG was detected in 22 (12.0%) patients and anti-HEV immunoglobulin M in 3 (1.6%). HEV RNA showed inconclusive results in nine (4.9%) patients and was undetectable in the remaining patients. HEV serology positive patients had more severe liver disease, characterized by liver fibrosis ≥3 versus ≤2 (p<0.001), Aspartate Aminotransferase-to-Platelet Ratio Index of ≥1.45 (p=0.003), and Fibrosis-4 score of ≥3.25 (p=0.001). Additionally, the odds of HEV-positive patients developing diabetes mellitus were 3.65 (95% CI 1.40-9.52) times the corresponding odds of HEV-negative patients. A case-control-based histological analysis (n=11 HEV-HCV-positive patients and n=22 HCV-positive patients) showed no significant differences between the groups. CONCLUSIONS: This prevalence is higher than that reported in previous studies of the general population in Brazil. Thus, HEV infection may influence the severity of liver disease and may represent an additional risk of developing diabetes mellitus in patients with HCV infection.
publishDate 2021
dc.date.none.fl_str_mv 2021-11-26
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/212958
10.6061/clinics/2021/e3270
url https://www.revistas.usp.br/clinics/article/view/212958
identifier_str_mv 10.6061/clinics/2021/e3270
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/212958/194988
dc.rights.driver.fl_str_mv Copyright (c) 2023 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 76 (2021); e3270
Clinics; v. 76 (2021); e3270
Clinics; Vol. 76 (2021); e3270
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222766140489728